Serum - Protection from birth onwards
Ganirelix Acetate for Injection 0.25 mg
Ganirelix acetate injection is indicated for the inhibition of premature LH surges in women undergoing controlled ovarian hyperstimulation.
Ganirelix acetate injection is for subcutaneous use only.
After initiating FSH therapy on Day 2 or 3 of the cycle, Ganirelix Acetate Injection 250 mcg may be administered subcutaneously once daily during the mid to late portion of the follicular phase.
Treatment with Ganirelix Acetate should be continued daily until the day of hCG administration.
1 Pre-filled Syringe (PFS)
